Chularat Hospital PCL (BKK:CHG)

Chularat Hospital PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	8,063	8,237	7,730	10,103	11,742	5,433
Other Revenue	69.47	243.52	284.13	304.57	257.29	28.86
Revenue	8,132	8,480	8,014	10,408	11,999	5,462
Revenue Growth (YoY)	-6.88%	5.81%	-22.99%	-13.26%	119.70%	5.28%
Cost of Revenue	5,909	6,068	5,631	5,908	5,882	3,685
Gross Profit	2,223	2,413	2,384	4,500	6,117	1,777
Selling, General & Admin	1,144	1,127	1,003	934.88	821.27	673.2
Operating Expenses	1,144	1,127	1,003	934.88	821.27	673.2
Operating Income	1,079	1,286	1,381	3,565	5,296	1,104
Interest Expense	-29.67	-34.52	-24	-16.28	-21.38	-35.64
Interest & Investment Income	13.21	14.11	8.66	6.08	1.9	2.77
Earnings From Equity Investments	-15.9	-20.07	-19.35	-1.11	-	-
Pretax Income	1,046	1,245	1,346	3,554	5,276	1,071
Income Tax Expense	221.85	267.26	279.09	703.37	1,009	218.73
Earnings From Continuing Operations	824.35	977.96	1,067	2,850	4,267	852.36
Minority Interest in Earnings	-27.64	-12.74	-21.21	-71.68	-63.22	24.26
Net Income	796.71	965.22	1,046	2,778	4,204	876.62
Net Income to Common	796.71	965.22	1,046	2,778	4,204	876.62
Net Income Growth	-30.57%	-7.73%	-62.35%	-33.91%	379.58%	24.30%
Shares Outstanding (Basic)	11,000	11,000	11,000	11,000	11,000	11,000
Shares Outstanding (Diluted)	11,000	11,000	11,000	11,000	11,000	11,000
EPS (Basic)	0.07	0.09	0.10	0.25	0.38	0.08
EPS (Diluted)	0.07	0.09	0.10	0.25	0.38	0.08
EPS Growth	-30.57%	-7.73%	-62.35%	-33.91%	379.58%	24.30%
Free Cash Flow	1,190	1,149	987.1	1,843	3,525	1,008
Free Cash Flow Per Share	0.11	0.10	0.09	0.17	0.32	0.09
Dividend Per Share	0.070	0.070	0.070	0.160	0.200	0.050
Dividend Growth	-	-	-56.25%	-20.00%	300.00%	-
Gross Margin	27.33%	28.45%	29.74%	43.23%	50.98%	32.54%
Operating Margin	13.26%	15.16%	17.23%	34.25%	44.13%	20.21%
Profit Margin	9.80%	11.38%	13.05%	26.70%	35.04%	16.05%
Free Cash Flow Margin	14.63%	13.55%	12.32%	17.71%	29.38%	18.46%
EBITDA	1,547	1,749	1,797	3,921	5,623	1,437
EBITDA Margin	19.02%	20.62%	22.42%	37.67%	46.86%	26.32%
D&A For EBITDA	468.09	463.31	415.65	355.71	327.11	333.37
EBIT	1,079	1,286	1,381	3,565	5,296	1,104
EBIT Margin	13.26%	15.16%	17.23%	34.25%	44.13%	20.21%
Effective Tax Rate	21.21%	21.46%	20.73%	19.79%	19.12%	20.42%
Revenue as Reported	8,132	8,480	8,014	10,408	11,999	5,462

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.